$-0.07 EPS Expected for Acacia Communications, Inc. (ACIA); Amgen (AMGN) Shorts Lowered By 51.77%

April 23, 2018 - By Michael Collier

Amgen Inc. (NASDAQ:AMGN) Logo

Analysts expect Acacia Communications, Inc. (NASDAQ:ACIA) to report $-0.07 EPS on May, 8.They anticipate $0.93 EPS change or 108.14% from last quarter’s $0.86 EPS. After having $0.12 EPS previously, Acacia Communications, Inc.’s analysts see -158.33% EPS growth. The stock increased 0.65% or $0.18 during the last trading session, reaching $27.74. About 620,168 shares traded. Acacia Communications, Inc. (NASDAQ:ACIA) has declined 30.95% since April 23, 2017 and is downtrending. It has underperformed by 42.50% the S&P500.

Amgen Inc (NASDAQ:AMGN) had a decrease of 51.77% in short interest. AMGN’s SI was 9.49M shares in April as released by FINRA. Its down 51.77% from 19.69 million shares previously. With 5.05 million avg volume, 2 days are for Amgen Inc (NASDAQ:AMGN)’s short sellers to cover AMGN’s short positions. The SI to Amgen Inc’s float is 1.31%. The stock increased 2.97% or $5.1 during the last trading session, reaching $176.66. About 1.09M shares traded. Amgen Inc. (NASDAQ:AMGN) has risen 3.78% since April 23, 2017 and is uptrending. It has underperformed by 7.77% the S&P500.

Among 25 analysts covering Amgen Inc. (NASDAQ:AMGN), 11 have Buy rating, 0 Sell and 14 Hold. Therefore 44% are positive. Amgen Inc. had 88 analyst reports since August 3, 2015 according to SRatingsIntel. The firm has “Hold” rating given on Friday, September 22 by BMO Capital Markets. The firm has “Buy” rating by Argus Research given on Thursday, July 27. The company was maintained on Thursday, February 1 by Cowen & Co. Credit Suisse maintained the shares of AMGN in report on Friday, February 2 with “Neutral” rating. Barclays Capital maintained the stock with “Equal-Weight” rating in Thursday, April 5 report. The rating was maintained by Jefferies with “Buy” on Sunday, August 27. The stock of Amgen Inc. (NASDAQ:AMGN) earned “Buy” rating by Oppenheimer on Wednesday, August 23. As per Thursday, September 7, the company rating was maintained by Piper Jaffray. The rating was maintained by Oppenheimer with “Buy” on Friday, July 28. Cowen & Co maintained the stock with “Buy” rating in Thursday, July 20 report.

Since December 12, 2017, it had 0 insider purchases, and 5 selling transactions for $1.37 million activity. Harper Sean E sold $283,071 worth of stock.

Amgen Inc. discovers, develops, manufactures, and delivers human therapeutics worldwide. The company has market cap of $118.06 billion. It offers products for the treatment of oncology/hematology, cardiovascular, inflammation, bone health, nephrology, and neuroscience. It has a 65.67 P/E ratio. The companyÂ’s products include Evenity to treat osteoporosis in postmenopausal women; Prolia to treat postmenopausal women with osteoporosis; Xgeva for skeletal-related events prevention; Repatha to treat coronary artery diseases; Enbrel to treat plaque psoriasis, rheumatoid arthritis, and psoriatic arthritis; Parsabiv to treat secondary hyperparathyroidism ; and Erenumab for the prevention of migraine.

Investors sentiment increased to 1.22 in Q4 2017. Its up 0.23, from 0.99 in 2017Q3. It increased, as 73 investors sold Amgen Inc. shares while 458 reduced holdings. 122 funds opened positions while 527 raised stakes. 551.71 million shares or 0.60% less from 555.05 million shares in 2017Q3 were reported. Parametrica Management Limited holds 1,163 shares or 0.13% of its portfolio. Boyd Watterson Asset Mngmt Ltd Oh stated it has 0.47% of its portfolio in Amgen Inc. (NASDAQ:AMGN). Quantum Mgmt reported 4,200 shares. First Merchants Corporation holds 0.04% or 1,424 shares. Howard Cap Mngmt reported 0.16% in Amgen Inc. (NASDAQ:AMGN). Bnp Paribas Arbitrage has 578,670 shares for 0.17% of their portfolio. Coho Ptnrs Ltd stated it has 4.02% in Amgen Inc. (NASDAQ:AMGN). Vanguard Group Incorporated reported 0.4% in Amgen Inc. (NASDAQ:AMGN). Ingalls And Snyder Limited Liability invested in 14,352 shares. Eagleclaw Cap Managment stated it has 0.12% of its portfolio in Amgen Inc. (NASDAQ:AMGN). Korea Investment has 0.54% invested in Amgen Inc. (NASDAQ:AMGN). Moreover, Great West Life Assurance Can has 0.27% invested in Amgen Inc. (NASDAQ:AMGN). Cornercap Inv Counsel stated it has 39,350 shares. Natl Bank Of Montreal Can has invested 0.39% in Amgen Inc. (NASDAQ:AMGN). Coastline Comm owns 14,240 shares for 0.37% of their portfolio.

Acacia Communications, Inc. develops, makes, and sells high-speed coherent optical interconnect products in the Americas, Europe, the Middle East, Africa, and the Asia Pacific region. The company has market cap of $1.11 billion. The Company’s products include a series of low-power coherent digital signal processors application-specific integrated circuits and silicon photonic integrated circuits integrated into families of optical interconnect modules with transmission speeds ranging from 100 to 400 gigabits per second for use in long-haul, metro, and inter-data center markets. It has a 30.15 P/E ratio. The firm sells its products through a direct sales force to network equipment manufacturers.

Among 5 analysts covering Acacia Communications (NASDAQ:ACIA), 3 have Buy rating, 0 Sell and 2 Hold. Therefore 60% are positive. Acacia Communications had 9 analyst reports since June 7, 2016 according to SRatingsIntel. Morgan Stanley initiated the stock with “Equal-Weight” rating in Thursday, December 8 report. The rating was initiated by Goldman Sachs with “Neutral” on Tuesday, June 7. Cowen & Co initiated Acacia Communications, Inc. (NASDAQ:ACIA) on Tuesday, June 7 with “Outperform” rating. The stock has “Buy” rating by Needham on Tuesday, October 11. Needham maintained Acacia Communications, Inc. (NASDAQ:ACIA) rating on Friday, August 12. Needham has “Buy” rating and $100 target. The firm earned “Buy” rating on Friday, September 9 by Deutsche Bank. The company was initiated on Tuesday, June 7 by Deutsche Bank. Deutsche Bank maintained Acacia Communications, Inc. (NASDAQ:ACIA) rating on Thursday, July 14. Deutsche Bank has “Buy” rating and $60 target. Needham initiated the shares of ACIA in report on Tuesday, June 7 with “Buy” rating.

Amgen Inc. (NASDAQ:AMGN) Institutional Positions Chart

- Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with our FREE daily email newsletter.


Free Email Newsletter

Enter your email address below to get the latest news and analysts' ratings for your stocks with our FREE daily email newsletter:

Recent Posts